Ignite Creation Date:
2025-12-24 @ 4:47 PM
Ignite Modification Date:
2025-12-28 @ 1:08 AM
Study NCT ID:
NCT06241950
Status:
TERMINATED
Last Update Posted:
2025-11-20
First Post:
2024-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)
Sponsor:
Sarepta Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-10-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2024-01-26
First Submit QC Date:
None
Study First Post Date:
2024-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-11-20
Last Update Post Date Type:
ESTIMATED